De Novo Foodlabs
De Novo Foodlabs is a Raleigh-based biotech startup that produces NanoFerrin™, an animal-free, nature-identical lactoferrin ingredient via proprietary precision fermentation, supplying food, beverage, and nutrition companies.
- Company typePrivate
- Founded2021
- HeadquartersRaleigh, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What De Novo Foodlabs does
De Novo Foodlabs is a privately held biotech company founded in 2021 and headquartered in Raleigh, North Carolina. Originally launched as De Novo Dairy (Africa's first precision fermentation startup) and rebranded in 2022, the company develops nature-identical functional proteins via proprietary precision fermentation technology. Its flagship product, NanoFerrin™, is an animal-free lactoferrin—an iron-binding glycoprotein with antimicrobial, anti-inflammatory, gut-health, immune, cognitive, and anti-aging benefits—positioned as a sustainable, cost-effective alternative to traditional bovine lactoferrin extraction, with claimed reductions of 90% in greenhouse gas emissions and 95% in land and water use.
The company serves business customers in the food & beverage and nutrition & supplement industries, targeting product formulators, buyers, and innovators seeking consistent, scalable functional ingredients. Its go-to-market is enterprise B2B ingredient sales conducted directly with manufacturers, supported by scientific content marketing (whitepapers, industry press coverage, and partnerships) and led by a VP of Commercial (Marian Temesvary). Revenue is generated through ingredient sales; pricing is quote-based and not publicly disclosed. The company is pre- or very early revenue, having raised $4 million in total disclosed funding (August 2024 round led by Joyful Ventures) and maintains a 11-50 employee headcount weighted toward R&D and scientific roles.
De Novo's strategic positioning rests on a precision fermentation platform, a co-founder-led team with PhDs in food science and biochemistry, and commercial partnerships including Calidad Pascual (via Pascual Innoventures) and academic ties to Stellenbosch University. Key investors include Joyful Ventures, Sustainable Food Ventures, Cult Food Science, Big Idea Ventures, Inno Ventures, and UM6P Ventures. The company operates in the U.S. with historical ties to South Africa and targets the precision fermentation market, which is projected to grow from $5.93 billion in 2025 to $65 billion by 2032.
De Novo Foodlabs firmographics
Firmographics- Name
- De Novo Foodlabs
- Legal name
- De Novo Foods, Inc.
- Website
- https://denovofoodlabs.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- De Novo Foodlabs is a Raleigh-based biotech startup that produces NanoFerrin™, an animal-free, nature-identical lactoferrin ingredient via proprietary precision fermentation, supplying food, beverage, and nutrition companies.
- Ownership category
- akta.pro rank
Where De Novo Foodlabs is headquartered
LocationHeadquarters
- HQ city
- Raleigh
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
De Novo Foodlabs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Ingredient Sales: De Novo Foodlabs sells NanoFerrin™ as a functional ingredient to food, beverage, and nutrition companies. The B2B model involves selling the precision-fermented lactoferrin as an ingredient that companies incorporate into their products for health and longevity benefits.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
De Novo Foodlabs product offering
Product offeringCore offering
De Novo Foodlabs produces NanoFerrin™, an animal-free, nature-identical lactoferrin protein manufactured through proprietary precision fermentation. The company sells this functional protein ingredient to food, beverage, and nutrition companies as a sustainable, scalable, and cost-effective alternative to bovine-derived lactoferrin for use in immune, gut, cognitive, and anti-aging applications.
Product overview
De Novo Foodlabs is a single-product company focused on NanoFerrin™, an animal-free lactoferrin ingredient produced via proprietary precision fermentation technology. The company positions this as a sustainable, cost-effective alternative to traditional bovine lactoferrin for the food, beverage, and supplement industries.
Differentiator
Problem solved
Functional benefit
Brands
- NanoFerrin™: Animal-free, precision-fermented lactoferrin protein product delivering health and longevity benefits including antimicrobial, anti-inflammatory, gut health, immune system support, and cognitive and anti-aging benefits.
Products and services
- NanoFerrin™ NanoFerrin™ is an animal-free lactoferrin protein produced through proprietary precision fermentation technology. It delivers the health benefits of traditional bovine lactoferrin—including antimicrobial and anti-inflammatory properties, gut health support, immune system boosting, and cognitive and anti-aging benefits—through consistent, scalable, and cost-effective production. It is sold to food, beverage, and nutrition companies as a functional protein ingredient.
Quantifiable outcome
- 90% reduction in greenhouse gas emissions
- +1 more outcomes
Companies that use De Novo Foodlabs
Customer profileSegments3 records
Ideal customer profiles2 records
De Novo Foodlabs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
De Novo Foodlabs partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Stellenbosch UniversitycoreAcademic partnership with Dr. Shaunita Rose collaborating on research. Dr. Erick Strauss serves on De Novo's Advisory Board as Professor in Biochemistry. Stellenbosch University supports the company's research and innovation in bioscience.
- Pascual (Calidad Pascual)corePartnership through Pascual Innoventures aims to capitalize on changes in the food industry and provide consumers with sustainable and healthy food options. Gabriel Torres leads Pascual's collaboration, bringing distribution channels and assets together with De Novo's technology.
- WellfoundedminorPartner organization working with De Novo Foodlabs, with Alexandra Emerson-White providing testimonial about the company's expertise and innovative products.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
De Novo Foodlabs competitors and assessment
Company assessmentDirect peers
- Helaina: Helaina produces precision-fermented human-identical lactoferrin (effera™) for infant nutrition and functional food applications. It is the closest direct competitor to De Novo's NanoFerrin™ in both product and customer segment.
- TurtleTree: TurtleTree uses precision fermentation to produce functional dairy proteins, with lactoferrin among its targeted ingredients. It competes head-to-head with De Novo in the animal-free functional protein ingredient space.
- Remilk: Remilk produces animal-free dairy proteins, including beta-lactoglobulin, via precision fermentation for food and beverage applications. It is comparable to De Novo in technology platform and target customers, though focused on different proteins.
- Imagindairy: Imagindairy develops precision-fermented dairy proteins for the food industry, with a similar B2B ingredient supplier model to De Novo. Comparable in stage and application focus.
- Standing Ovation: Standing Ovation uses precision fermentation to produce animal-free casein proteins for cheese applications. Comparable technology platform and B2B ingredient go-to-market to De Novo Foodlabs.
- Bon Vivant: Bon Vivant develops precision-fermented dairy proteins targeting the European food industry, with comparable platform technology and ingredient supplier model to De Novo Foodlabs.
- Vivici: Vivici produces animal-free dairy proteins using precision fermentation for food, beverage, and nutrition applications. Comparable technology stack and B2B ingredient business model.
- Onego Bio: Onego Bio uses precision fermentation to produce animal-free egg proteins, including lactoferrin. Highly comparable technology platform and target market overlap with De Novo Foodlabs.
Broad incumbents
- Perfect Day: Perfect Day is the most well-capitalized precision fermentation company producing animal-free whey protein at commercial scale. While its focus is broader than lactoferrin, it competes for the same CPG ingredient budgets and sustainability narratives.
- Fonterra: Fonterra is a major global dairy cooperative that produces traditional bovine lactoferrin and is also investing in precision fermentation capabilities. It represents both a potential competitor and a partner/channel for De Novo's ingredient.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
De Novo Foodlabs social profiles
Digital presenceDe Novo Foodlabs financial estimates
Financial estimateRevenue estimate
Valuation estimate
De Novo Foodlabs leadership team
Management profileNumber of profiles
Profiles1 record
De Novo Foodlabs funding detail
Funding detailFunding overview
Funding rounds6 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
De Novo Foodlabs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about De Novo Foodlabs
What does De Novo Foodlabs do?
De Novo Foodlabs produces NanoFerrin™, an animal-free, nature-identical lactoferrin protein manufactured through proprietary precision fermentation. The company sells this functional protein ingredient to food, beverage, and nutrition companies as a sustainable, scalable, and cost-effective alternative to bovine-derived lactoferrin for use in immune, gut, cognitive, and anti-aging applications.
Is De Novo Foodlabs a public or private company?
De Novo Foodlabs is a private company. It is classified as venture growth investor backed and is currently operating.
When was De Novo Foodlabs founded?
De Novo Foodlabs was founded in 2021. It employs 11 to 50 people.
Where is De Novo Foodlabs based?
De Novo Foodlabs is headquartered in Raleigh, United States, in the North America region.
How does De Novo Foodlabs make money?
One revenue line is on record: ingredient Sales.
Who are De Novo Foodlabs's main competitors?
Direct peers on record are Helaina, TurtleTree, Remilk, Imagindairy, Standing Ovation, Bon Vivant, Vivici and Onego Bio. Broad incumbents are Perfect Day and Fonterra.
Does De Novo Foodlabs have an API?
No public API is recorded for De Novo Foodlabs.